Lyra Therapeutics Inc (LYRA) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lyra Therapeutics Inc   (NASDAQ: LYRA)

Lyra Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Lyra Therapeutics Inc in the fourth quarter 2025?
Due to the lack of equity, it was not possible to calculate Lyra Therapeutics Inc 's return on equity (ROE) in its fourth quarter 2025

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change - - -94.76 % -95 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -29 -33 -39 -80 -93
Return On Equity (TTM) - -1032.82 % -411.98 % -474.37 % -265.64 %
LYRA's Total Ranking # 3721 # 3674 # 3319 # 2242 # 2707
Equity (TTM) in Millions -11 -4 2 4 12
Seq. Equity Change - - -58.11 % -66.6 % -43.77 %
Seq. Net Income Change - - - - -

Back to LYRA Management Effectiveness >> LYRA's 5 Years Annual ROE >> Compare LYRA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 171
Sector # 754
Overall # 3721

Return On Equity Statistics
High Average Low
-33.18 %
-184.06 %
-1032.82 %
(Mar 31 2021)   (Sep 30 2025)





LYRA Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions -11 12 89 81 34
Y / Y Equity Change - -87.03 % 10.73 % 135.32 % -53.93 %
Net Income in Millions -29 -93 -63 -55 -44
Y / Y Net Income Change - - - - -
Return On Equity - -805.89 % -70.1 % -68.45 % -126.8 %

Back to LYRA Management Effectiveness >> LYRA's 5 Years Annual ROE >> Compare LYRA ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LYRA's' Return on Equity at Yahoo Finance
LYRA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LYRA's Competitors
Subscribers only: Roe for Lyra Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for LYRA's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Q32 Bio Inc   1,630.23 %
Aveanna Healthcare Holdings Inc   983.51 %
Petros Pharmaceuticals inc   858.01 %
Coherus Oncology inc   789.35 %
Omada Health Inc   630.34 %
Interpace Biosciences Inc   484.95 %
Glucotrack Inc   393.33 %
Silexion Therapeutics Corp  387.82 %
Lifemd Inc   360.74 %
Oncotelic Therapeutics Inc   350.26 %
Traws Pharma inc   273.56 %
Scisparc Ltd  244.10 %

Date modified: 2026-07-07T12:01:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.